Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1998 Oct;106(Suppl 5):1229–1234. doi: 10.1289/ehp.98106s51229

Lipid peroxidation products and antioxidants in human disease.

F J Romero 1, F Bosch-Morell 1, M J Romero 1, E J Jareño 1, B Romero 1, N Marín 1, J Romá 1
PMCID: PMC1533372  PMID: 9788902

Abstract

Lipid peroxidation (LPO) is a free radical-related process that in biologic systems may occur under enzymatic control, e.g., for the generation of lipid-derived inflammatory mediators, or nonenzymatically. This latter form is associated mostly with cellular damage as a result of oxidative stress, which also involves cellular antioxidants in this process. This article focuses on the relevance of two LPO products, malondialdehyde (MDA) and 4-hydroxynonenal (HNE), to the pathophysiology of human disease. The former has been studied in human serum samples of hepatitis C virus-infected adults and human immunodeficiency virus-infected children. In these two cases it is shown that the specific assay of serum MDA is useful for the clinical management of these patients. The presence of MDA in subretinal fluid of patients with retinal detachment suggests the involvement of oxidative stress in this process. Moreover, we were able to report the dependence of this involvement on the degree of myopia in these patients. The assay of MDA contents in the peripheral nerves of rats fed a chronic alcohol-containing diet or diabetic mice also confirms the pathophysiologic role of oxidative stress in these experimental models. In these two cases, associated with an increase in tissue LPO products content, we detected a decrease of glutathione peroxidase (GSHPx) activity in peripheral nerve, among other modifications. We have demonstrated that in vitro HNE is able to inhibit GSHPx activity in an apparent competitive manner, and that glutathione may partially protect and/or prevent this inactivation. The accumulation of LPO products in the brain of patients with Alzheimer's disease has also been described, and it is on the basis of this observation that we have tried to elucidate the role of oxidative stress and cellular antioxidants in beta-amyloid-induced apoptotic cell death of rat embryo neurons. Finally, we discuss the possible role of the observed vascular effects of HNE on human arteries.

Full text

PDF
1229

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alter H. J. Clinical, virological and epidemiological basis for the treatment of chronic non-A, non-B hepatitis. J Hepatol. 1990;11 (Suppl 1):S19–S25. doi: 10.1016/0168-8278(90)90158-n. [DOI] [PubMed] [Google Scholar]
  2. Alter H. J., Holland P. V., Morrow A. G., Purcell R. H., Feinstone S. M., Moritsugu Y. Clinical and serological analysis of transfusion-associated hepatitis. Lancet. 1975 Nov 1;2(7940):838–841. doi: 10.1016/s0140-6736(75)90234-2. [DOI] [PubMed] [Google Scholar]
  3. Arpadi S., Caspe W. B. Guidelines for the care of children and adolescents with HIV infection. HIV testing. J Pediatr. 1991 Jul;119(1 Pt 2):S8–13. doi: 10.1016/s0022-3476(05)81446-5. [DOI] [PubMed] [Google Scholar]
  4. Barbaro G., Di Lorenzo G., Soldini M., Parrotto S., Bellomo G., Belloni G., Grisorio B., Barbarini G. Hepatic glutathione deficiency in chronic hepatitis C: quantitative evaluation in patients who are HIV positive and HIV negative and correlations with plasmatic and lymphocytic concentrations and with the activity of the liver disease. Am J Gastroenterol. 1996 Dec;91(12):2569–2573. [PubMed] [Google Scholar]
  5. Bazan N. G. The metabolism of omega-3 polyunsaturated fatty acids in the eye: the possible role of docosahexaenoic acid and docosanoids in retinal physiology and ocular pathology. Prog Clin Biol Res. 1989;312:95–112. [PubMed] [Google Scholar]
  6. Berger A., von Depka Prondzinski M., Doerr H. W., Rabenau H., Weber B. Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection. J Med Virol. 1996 Apr;48(4):339–343. doi: 10.1002/(SICI)1096-9071(199604)48:4<339::AID-JMV7>3.0.CO;2-8. [DOI] [PubMed] [Google Scholar]
  7. Bosch-Morell F., Martínez-Soriano F., Colell A., Fernández-Checa J. C., Romero F. J. Chronic ethanol feeding induces cellular antioxidants decrease and oxidative stress in rat peripheral nerves. Effect of S-adenosyl-L-methionine and N-acetyl-L-cysteine. Free Radic Biol Med. 1998 Aug;25(3):365–368. doi: 10.1016/s0891-5849(98)00036-7. [DOI] [PubMed] [Google Scholar]
  8. Bosch-Morell F., Sanz A., Díaz-Llopis M., Romero F. J. Lipid peroxidation products in human subretinal fluid. Free Radic Biol Med. 1996;20(7):899–903. doi: 10.1016/0891-5849(95)02219-8. [DOI] [PubMed] [Google Scholar]
  9. Braughler J. M., Hall E. D. Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radic Biol Med. 1989;6(3):289–301. doi: 10.1016/0891-5849(89)90056-7. [DOI] [PubMed] [Google Scholar]
  10. Buhl R., Jaffe H. A., Holroyd K. J., Wells F. B., Mastrangeli A., Saltini C., Cantin A. M., Crystal R. G. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet. 1989 Dec 2;2(8675):1294–1298. doi: 10.1016/s0140-6736(89)91909-0. [DOI] [PubMed] [Google Scholar]
  11. Cavert W., Notermans D. W., Staskus K., Wietgrefe S. W., Zupancic M., Gebhard K., Henry K., Zhang Z. Q., Mills R., McDade H. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science. 1997 May 9;276(5314):960–964. doi: 10.1126/science.276.5314.960. [DOI] [PubMed] [Google Scholar]
  12. Ceballos I., Javoy-Agid F., Delacourte A., Defossez A., Nicole A., Sinet P. M. Parkinson's disease and Alzheimer's disease: neurodegenerative disorders due to brain antioxidant system deficiency? Adv Exp Med Biol. 1990;264:493–498. doi: 10.1007/978-1-4684-5730-8_75. [DOI] [PubMed] [Google Scholar]
  13. Danielson U. H., Esterbauer H., Mannervik B. Structure-activity relationships of 4-hydroxyalkenals in the conjugation catalysed by mammalian glutathione transferases. Biochem J. 1987 Nov 1;247(3):707–713. doi: 10.1042/bj2470707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dorey C. K., Khouri G. G., Syniuta L. A., Curran S. A., Weiter J. J. Superoxide production by porcine retinal pigment epithelium in vitro. Invest Ophthalmol Vis Sci. 1989 Jun;30(6):1047–1054. [PubMed] [Google Scholar]
  15. Eck H. P., Stahl-Hennig C., Hunsmann G., Dröge W. Metabolic disorder as early consequence of simian immunodeficiency virus infection in rhesus macaques. Lancet. 1991 Aug 10;338(8763):346–347. doi: 10.1016/0140-6736(91)90482-5. [DOI] [PubMed] [Google Scholar]
  16. Esterbauer H., Cheeseman K. H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 1990;186:407–421. doi: 10.1016/0076-6879(90)86134-h. [DOI] [PubMed] [Google Scholar]
  17. Esterbauer H., Schaur R. J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 1991;11(1):81–128. doi: 10.1016/0891-5849(91)90192-6. [DOI] [PubMed] [Google Scholar]
  18. Fahey J. L., Taylor J. M., Detels R., Hofmann B., Melmed R., Nishanian P., Giorgi J. V. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med. 1990 Jan 18;322(3):166–172. doi: 10.1056/NEJM199001183220305. [DOI] [PubMed] [Google Scholar]
  19. Fuchs J., Schöfer H., Milbradt R., Freisleben H. J., Buhl R., Siems W., Grune T. Studies on lipoate effects on blood redox state in human immunodeficiency virus infected patients. Arzneimittelforschung. 1993 Dec;43(12):1359–1362. [PubMed] [Google Scholar]
  20. Garcia-Fulgueiras A., Tormo M. J., Rodriguez T., Perez-Flores D., Chirlaque D., Navarro C. Prevalence of hepatitis B and C markers in the south-east of Spain: an unlinked community-based serosurvey of 2,203 adults. Scand J Infect Dis. 1996;28(1):17–20. doi: 10.3109/00365549609027143. [DOI] [PubMed] [Google Scholar]
  21. Goto H., Wu G. S., Gritz D. C., Atalla L. R., Rao N. A. Chemotactic activity of the peroxidized retinal membrane lipids in experimental autoimmune uveitis. Curr Eye Res. 1991 Nov;10(11):1009–1014. doi: 10.3109/02713689109020339. [DOI] [PubMed] [Google Scholar]
  22. Greenwald R. A., Moak S. A. Degradation of hyaluronic acid by polymorphonuclear leukocytes. Inflammation. 1986 Mar;10(1):15–30. doi: 10.1007/BF00916037. [DOI] [PubMed] [Google Scholar]
  23. Hackett S. F., Conway B. P., Campochiaro P. A. Subretinal fluid stimulation of retinal pigment epithelial cell migration and proliferation is dependent on certain features of the detachment or its treatment. Arch Ophthalmol. 1989 Mar;107(3):391–394. doi: 10.1001/archopht.1989.01070010401033. [DOI] [PubMed] [Google Scholar]
  24. Hall E. D., Braughler J. M. Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation. Free Radic Biol Med. 1989;6(3):303–313. doi: 10.1016/0891-5849(89)90057-9. [DOI] [PubMed] [Google Scholar]
  25. Hartley D. P., Lindahl R., Petersen D. R. Covalent modification of class 2 and class 3 aldehyde dehydrogenase by 4-hydroxynonenal. Adv Exp Med Biol. 1995;372:93–101. doi: 10.1007/978-1-4615-1965-2_13. [DOI] [PubMed] [Google Scholar]
  26. Hermenegildo C., Raya A., Romá J., Romero F. J. Decreased glutathione peroxidase activity in sciatic nerve of alloxan-induced diabetic mice and its correlation with blood glucose levels. Neurochem Res. 1993 Aug;18(8):893–896. doi: 10.1007/BF00998274. [DOI] [PubMed] [Google Scholar]
  27. Higueras V., Raya A., Rodrigo J. M., Serra M. A., Romá J., Romero F. J. Interferon decreases serum lipid peroxidation products of hepatitis C patients. Free Radic Biol Med. 1994 Jan;16(1):131–133. doi: 10.1016/0891-5849(94)90250-x. [DOI] [PubMed] [Google Scholar]
  28. Hubel C. A., Davidge S. T., McLaughlin M. K. Lipid hydroperoxides potentiate mesenteric artery vasoconstrictor responses. Free Radic Biol Med. 1993 Apr;14(4):397–407. doi: 10.1016/0891-5849(93)90089-d. [DOI] [PubMed] [Google Scholar]
  29. Inchauspé G. Protection and defence mechanisms in HCV infection. Nephrol Dial Transplant. 1996;11 (Suppl 4):6–8. doi: 10.1093/ndt/11.supp4.6. [DOI] [PubMed] [Google Scholar]
  30. Iuliano R., Pizzigallo A. M., Alecci A., Barsanti L., Trovato R., Forastieri G., Lico S., Palmieri C., Brizzi M., Marino N. Quantitation of HCV viraemia by branched DNA signal amplification in patients treated with alpha-interferon--a longitudinal study. Infection. 1996 Jul-Aug;24(4):292–296. doi: 10.1007/BF01743362. [DOI] [PubMed] [Google Scholar]
  31. Jareño E. J., Bosch-Morell F., Fernández-Delgado R., Donat J., Romero F. J. Serum malondialdehyde in HIV seropositive children. Free Radic Biol Med. 1998 Feb;24(3):503–506. doi: 10.1016/s0891-5849(97)00168-8. [DOI] [PubMed] [Google Scholar]
  32. Jareño E. J., Bosch-Morell F., Fernández-Delgado R., Donat J., Romero F. J. Serum malondialdehyde in HIV-seropositive children negatively correlates with CD4+ lymphocytes count. Biofactors. 1998;8(1-2):129–132. doi: 10.1002/biof.5520080121. [DOI] [PubMed] [Google Scholar]
  33. Jensson H., Guthenberg C., Alin P., Mannervik B. Rat glutathione transferase 8-8, an enzyme efficiently detoxifying 4-hydroxyalk-2-enals. FEBS Lett. 1986 Jul 28;203(2):207–209. doi: 10.1016/0014-5793(86)80743-8. [DOI] [PubMed] [Google Scholar]
  34. Kamimura S., Gaal K., Britton R. S., Bacon B. R., Triadafilopoulos G., Tsukamoto H. Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: association of lipid peroxidation with liver fibrogenesis. Hepatology. 1992 Aug;16(2):448–453. doi: 10.1002/hep.1840160225. [DOI] [PubMed] [Google Scholar]
  35. Kaneko T., Kaji K., Matsuo M. Cytotoxicities of a linoleic acid hydroperoxide and its related aliphatic aldehydes toward cultured human umbilical vein endothelial cells. Chem Biol Interact. 1988;67(3-4):295–304. doi: 10.1016/0009-2797(88)90065-8. [DOI] [PubMed] [Google Scholar]
  36. Kihara M., Schmelzer J. D., Poduslo J. F., Curran G. L., Nickander K. K., Low P. A. Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals. Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6107–6111. doi: 10.1073/pnas.88.14.6107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Kondo M., Tanaka K., Ikeda M., Arata S., Saito S., Sakaguchi T., Morimoto M., Fujii T., Mitsui K., Okazaki H. Hepatic HCV-RNA as a predictor of outcome after interferon therapy in patients with chronic hepatitis C. J Gastroenterol Hepatol. 1996 Mar;11(3):236–240. doi: 10.1111/j.1440-1746.1996.tb00068.x. [DOI] [PubMed] [Google Scholar]
  38. LeBel C. P., Bondy S. C. Oxygen radicals: common mediators of neurotoxicity. Neurotoxicol Teratol. 1991 May-Jun;13(3):341–346. doi: 10.1016/0892-0362(91)90081-7. [DOI] [PubMed] [Google Scholar]
  39. Low P. A., Nickander K. K. Oxygen free radical effects in sciatic nerve in experimental diabetes. Diabetes. 1991 Jul;40(7):873–877. doi: 10.2337/diab.40.7.873. [DOI] [PubMed] [Google Scholar]
  40. Mark R. J., Lovell M. A., Markesbery W. R., Uchida K., Mattson M. P. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J Neurochem. 1997 Jan;68(1):255–264. doi: 10.1046/j.1471-4159.1997.68010255.x. [DOI] [PubMed] [Google Scholar]
  41. Martínez-Blasco A., Bosch-Morell F., Trenor C., Romero F. J. Experimental diabetic neuropathy: role of oxidative stress and mechanisms involved. Biofactors. 1998;8(1-2):41–43. doi: 10.1002/biof.5520080108. [DOI] [PubMed] [Google Scholar]
  42. Martínez M. C., Bosch-Morell F., Raya A., Romá J., Aldasoro M., Vila J., Lluch S., Romero F. J. 4-Hydroxynonenal, a lipid peroxidation product, induces relaxation of human cerebral arteries. J Cereb Blood Flow Metab. 1994 Jul;14(4):693–696. doi: 10.1038/jcbfm.1994.87. [DOI] [PubMed] [Google Scholar]
  43. McNeil J. D., Wiebkin O. W., Betts W. H., Cleland L. G. Depolymerisation products of hyaluronic acid after exposure to oxygen-derived free radicals. Ann Rheum Dis. 1985 Nov;44(11):780–789. doi: 10.1136/ard.44.11.780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Meister A. Glutathione metabolism and its selective modification. J Biol Chem. 1988 Nov 25;263(33):17205–17208. [PubMed] [Google Scholar]
  45. Müller W. E., Romero F. J., Perovic S., Pergande G., Pialoglou P. Protection of flupirtine on beta-amyloid-induced apoptosis in neuronal cells in vitro: prevention of amyloid-induced glutathione depletion. J Neurochem. 1997 Jun;68(6):2371–2377. doi: 10.1046/j.1471-4159.1997.68062371.x. [DOI] [PubMed] [Google Scholar]
  46. Nabel G., Baltimore D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature. 1987 Apr 16;326(6114):711–713. doi: 10.1038/326711a0. [DOI] [PubMed] [Google Scholar]
  47. Nagamatsu M., Nickander K. K., Schmelzer J. D., Raya A., Wittrock D. A., Tritschler H., Low P. A. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care. 1995 Aug;18(8):1160–1167. doi: 10.2337/diacare.18.8.1160. [DOI] [PubMed] [Google Scholar]
  48. Pigeolet E., Corbisier P., Houbion A., Lambert D., Michiels C., Raes M., Zachary M. D., Remacle J. Glutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals. Mech Ageing Dev. 1990 Feb 15;51(3):283–297. doi: 10.1016/0047-6374(90)90078-t. [DOI] [PubMed] [Google Scholar]
  49. Puertas F. J., Díaz-Llopis M., Chipont E., Romá J., Raya A., Romero F. J. Glutathione system of human retina: enzymatic conjugation of lipid peroxidation products. Free Radic Biol Med. 1993 May;14(5):549–551. doi: 10.1016/0891-5849(93)90112-8. [DOI] [PubMed] [Google Scholar]
  50. Quiroga J. A., Bosch O., Gonzalez R., Marriott E., Castillo I., Bartolome J., Carreño V. Immunoglobulin M antibody to hepatitis C virus during interferon therapy for chronic hepatitis C. Gastroenterology. 1992 Oct;103(4):1285–1289. doi: 10.1016/0016-5085(92)91517-8. [DOI] [PubMed] [Google Scholar]
  51. Quiroga J. A., Martin J., Pardo M., Carreño V. Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-alpha. Dig Dis Sci. 1994 Nov;39(11):2485–2496. doi: 10.1007/BF02087671. [DOI] [PubMed] [Google Scholar]
  52. Roederer M., Staal F. J., Raju P. A., Ela S. W., Herzenberg L. A., Herzenberg L. A. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4884–4888. doi: 10.1073/pnas.87.12.4884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Romero F. J. Antioxidants in peripheral nerve. Free Radic Biol Med. 1996;20(7):925–932. doi: 10.1016/0891-5849(95)02183-3. [DOI] [PubMed] [Google Scholar]
  54. Romero F. J., Monsalve E., Hermenegildo C., Puertas F. J., Higueras V., Nies E., Segura-Aguilar J., Romá J. Oxygen toxicity in the nervous tissue: comparison of the antioxidant defense of rat brain and sciatic nerve. Neurochem Res. 1991 Feb;16(2):157–161. doi: 10.1007/BF00965704. [DOI] [PubMed] [Google Scholar]
  55. Romero F. J., Romero M. J., Bosch-Morell F., Martínez M. C., Medina P., Lluch S. 4-hydroxynonenal-induced relaxation of human mesenteric arteries. Free Radic Biol Med. 1997;23(3):521–523. doi: 10.1016/s0891-5849(97)00119-6. [DOI] [PubMed] [Google Scholar]
  56. Romero F. J., Zukowski D., Mueller-Klieser W. Glutathione content of V79 cells in two- or three-dimensional culture. Am J Physiol. 1997 May;272(5 Pt 1):C1507–C1512. doi: 10.1152/ajpcell.1997.272.5.C1507. [DOI] [PubMed] [Google Scholar]
  57. Selley M. L., Bartlett M. R., McGuiness J. A., Hapel A. J., Ardlie N. G. Determination of the lipid peroxidation product trans-4-hydroxy-2-nonenal in biological samples by high-performance liquid chromatography and combined capillary column gas chromatography-negative-ion chemical ionisation mass spectrometry. J Chromatogr. 1989 Mar 24;488(2):329–340. doi: 10.1016/s0378-4347(00)82957-6. [DOI] [PubMed] [Google Scholar]
  58. Seymour C. A. Asymptomatic infection with hepatitis C virus. BMJ. 1994 Mar 12;308(6930):670–671. doi: 10.1136/bmj.308.6930.670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Siems W. G., Hapner S. J., van Kuijk F. J. 4-hydroxynonenal inhibits Na(+)-K(+)-ATPase. Free Radic Biol Med. 1996;20(2):215–223. doi: 10.1016/0891-5849(95)02041-1. [DOI] [PubMed] [Google Scholar]
  60. Sies H. Ebselen, a selenoorganic compound as glutathione peroxidase mimic. Free Radic Biol Med. 1993 Mar;14(3):313–323. doi: 10.1016/0891-5849(93)90028-s. [DOI] [PubMed] [Google Scholar]
  61. Sies H. Ebselen. Methods Enzymol. 1995;252:341–342. doi: 10.1016/0076-6879(95)52037-6. [DOI] [PubMed] [Google Scholar]
  62. Soetjipto, Handajani R., Lusida M. I., Darmadi S., Adi P., Soemarto, Ishido S., Katayama Y., Hotta H. Differential prevalence of hepatitis C virus subtypes in healthy blood donors, patients on maintenance hemodialysis, and patients with hepatocellular carcinoma in Surabaya, Indonesia. J Clin Microbiol. 1996 Dec;34(12):2875–2880. doi: 10.1128/jcm.34.12.2875-2880.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Staal F. J., Roederer M., Israelski D. M., Bubp J., Mole L. A., McShane D., Deresinski S. C., Ross W., Sussman H., Raju P. A. Intracellular glutathione levels in T cell subsets decrease in HIV-infected individuals. AIDS Res Hum Retroviruses. 1992 Feb;8(2):305–311. doi: 10.1089/aid.1992.8.305. [DOI] [PubMed] [Google Scholar]
  64. Stanley A. J., Haydon G. H., Piris J., Jarvis L. M., Hayes P. C. Assessment of liver histology in patients with hepatitis C and normal transaminase levels. Eur J Gastroenterol Hepatol. 1996 Sep;8(9):869–872. [PubMed] [Google Scholar]
  65. Stuyver L., Fretz C., Esquivel C., Boudifa A., Jaulmes D., Azar N., Lunel F., Leroux-Roels G., Maertens G., Fournel J. J. Hepatitis C virus (HCV) genotype analysis in apparently healthy anti-HCV-positive Parisian blood donors. Transfusion. 1996 Jun;36(6):552–558. doi: 10.1046/j.1537-2995.1996.36696269516.x. [DOI] [PubMed] [Google Scholar]
  66. Suematsu T., Kamada T., Abe H., Kikuchi S., Yagi K. Serum lipoperoxide level in patients suffering from liver diseases. Clin Chim Acta. 1977 Aug 15;79(1):267–270. doi: 10.1016/0009-8981(77)90486-7. [DOI] [PubMed] [Google Scholar]
  67. Suematsu T., Matsumura T., Sato N., Miyamoto T., Ooka T., Kamada T., Abe H. Lipid peroxidation in alcoholic liver disease in humans. Alcohol Clin Exp Res. 1981 Summer;5(3):427–430. doi: 10.1111/j.1530-0277.1981.tb04926.x. [DOI] [PubMed] [Google Scholar]
  68. Suzuki Y. J., Aggarwal B. B., Packer L. Alpha-lipoic acid is a potent inhibitor of NF-kappa B activation in human T cells. Biochem Biophys Res Commun. 1992 Dec 30;189(3):1709–1715. doi: 10.1016/0006-291x(92)90275-p. [DOI] [PubMed] [Google Scholar]
  69. Szweda L. I., Uchida K., Tsai L., Stadtman E. R. Inactivation of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Selective modification of an active-site lysine. J Biol Chem. 1993 Feb 15;268(5):3342–3347. [PubMed] [Google Scholar]
  70. Sönnerborg A., Carlin G., Akerlund B., Jarstrand C. Increased production of malondialdehyde in patients with HIV infection. Scand J Infect Dis. 1988;20(3):287–290. doi: 10.3109/00365548809032453. [DOI] [PubMed] [Google Scholar]
  71. Tsai S. L., Liaw Y. F., Chen M. H., Huang C. Y., Kuo G. C. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology. 1997 Feb;25(2):449–458. doi: 10.1002/hep.510250233. [DOI] [PubMed] [Google Scholar]
  72. Tsukamoto H. Oxidative stress, antioxidants, and alcoholic liver fibrogenesis. Alcohol. 1993 Nov-Dec;10(6):465–467. doi: 10.1016/0741-8329(93)90066-w. [DOI] [PubMed] [Google Scholar]
  73. Uchida K., Stadtman E. R. Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. Proc Natl Acad Sci U S A. 1992 May 15;89(10):4544–4548. doi: 10.1073/pnas.89.10.4544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Yagi K. Lipid peroxides and human diseases. Chem Phys Lipids. 1987 Nov-Dec;45(2-4):337–351. doi: 10.1016/0009-3084(87)90071-5. [DOI] [PubMed] [Google Scholar]
  75. van der Kraaij A. M., de Jonge H. R., Esterbauer H., de Vente J., Steinbusch H. W., Koster J. F. Cumene hydroperoxide, an agent inducing lipid peroxidation, and 4-hydroxy-2,3-nonenal, a peroxidation product, cause coronary vasodilatation in perfused rat hearts by a cyclic nucleotide independent mechanism. Cardiovasc Res. 1990 Feb;24(2):144–150. doi: 10.1093/cvr/24.2.144. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES